Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on equity (ROE) is N/A as of the fiscal period ended Friday, December 31, 2021.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2022 (2021-12-31): 55.61%.
RETURN ON EQUITY (ROE)
N/A
RETURN ON EQUITY (ROE) AVG TTM
61.12%
RETURN ON EQUITY (ROE) AVG 3Y
-80.01%
RETURN ON EQUITY (ROE) AVG 5Y
31.48%
RETURN ON EQUITY (ROE) AVG 10Y
16.10%
RETURN ON EQUITY (ROE) AVG 15Y
17.31%
RETURN ON EQUITY (ROE) AVG 20Y
16.62%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Cardinal Health, Inc.
Market Cap
$55.01B
Return on Equity (ROE)
N/A
TTM Avg
61.12%
3Y Avg
-80.01%
5Y Avg
31.48%
Market Cap
$58.20B
Return on Equity (ROE)
-46.61%
TTM Avg
-32.64%
3Y Avg
-13.90%
5Y Avg
0.25%
Market Cap
$50.40B
Return on Equity (ROE)
3.85%
TTM Avg
6.60%
3Y Avg
6.50%
5Y Avg
6.42%
Market Cap
$49.24B
Return on Equity (ROE)
9.46%
TTM Avg
26.07%
3Y Avg
24.86%
5Y Avg
23.86%
Market Cap
$48.93B
Return on Equity (ROE)
6.65%
TTM Avg
7.05%
3Y Avg
11.93%
5Y Avg
15.09%
Market Cap
$63.47B
Return on Equity (ROE)
86.03%
TTM Avg
168.34%
3Y Avg
-32.99%
5Y Avg
148.52%
Market Cap
$45.09B
Return on Equity (ROE)
9.10%
TTM Avg
-6.34%
3Y Avg
-12.86%
5Y Avg
-14.53%
Market Cap
$43.73B
Return on Equity (ROE)
22.28%
TTM Avg
21.77%
3Y Avg
21.17%
5Y Avg
17.55%
Market Cap
$66.96B
Return on Equity (ROE)
14.71%
TTM Avg
10.21%
3Y Avg
8.16%
5Y Avg
6.40%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cardinal Health, Inc. (CAH) | $55.01B | N/A | 61.12% | -80.01% | 31.48% |
| Moderna, Inc. (MRNA)vs › | $58.20B | -46.61% | -32.64% | -13.90% | 0.25% |
| Becton, Dickinson and Company (BDX)vs › | $50.40B | 3.85% | 6.60% | 6.50% | 6.42% |
| Edwards Lifesciences Corporation (EW)vs › | $49.24B | 9.46% | 26.07% | 24.86% | 23.86% |
| Humana Inc. (HUM)vs › | $48.93B | 6.65% | 7.05% | 11.93% | 15.09% |
| Cencora, Inc. (COR)vs › | $63.47B | 86.03% | 168.34% | -32.99% | 148.52% |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $45.09B | 9.10% | -6.34% | -12.86% | -14.53% |
| IQVIA Holdings Inc. (IQV)vs › | $43.73B | 22.28% | 21.77% | 21.17% | 17.55% |
| Boston Scientific Corporation (BSX)vs › | $66.96B | 14.71% | 10.21% | 8.16% | 6.40% |
| Agilent Technologies, Inc. (A)vs › | $41.46B | 19.56% | 20.59% | 21.51% | 20.54% |
ROE
N/A
ROA
3.0%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2021-12-31 | 55.61% |
| 2021-09-30 | 81.48% |
| 2021-06-30 | 34.12% |
| 2021-03-31 | 64.30% |
| 2020-12-31 | 70.12% |
| 2020-09-30 | 68.42% |
| 2020-06-30 | -206.60% |
| 2020-03-31 | -345.64% |
| 2019-12-31 | -421.62% |
| 2019-09-30 | -461.33% |
| 2019-06-30 | 21.54% |
| 2019-03-31 | 0.05% |
| 2018-12-31 | -0.63% |
| 2018-09-30 | 12.43% |
| 2018-06-30 | 4.24% |
| 2018-03-31 | 22.52% |
| 2017-12-31 | 23.99% |
| 2017-09-30 | 16.38% |
| 2017-06-30 | 18.92% |
| 2017-03-31 | 20.27% |
| 2016-12-31 | 21.38% |
| 2016-09-30 | 20.79% |
| 2016-06-30 | 21.79% |
| 2016-03-31 | 20.71% |
| 2015-12-31 | 20.40% |
| 2015-09-30 | 20.48% |
| 2015-06-30 | 19.42% |
| 2015-03-31 | 18.12% |
| 2014-12-31 | 18.10% |
| 2014-09-30 | 17.47% |
| 2014-06-30 | 18.22% |
| 2014-03-31 | 5.30% |
| 2013-12-31 | 5.71% |
| 2013-09-30 | 6.37% |
| 2013-06-30 | 5.57% |
| 2013-03-31 | 16.91% |
| 2012-12-31 | 17.48% |
| 2012-09-30 | 17.55% |
| 2012-06-30 | 17.11% |
| 2012-03-31 | 16.58% |
| 2011-12-31 | 15.98% |
| 2011-09-30 | 15.77% |
| 2011-06-30 | 16.39% |
| 2011-03-31 | 17.32% |
| 2010-12-31 | 17.64% |
| 2010-09-30 | 18.61% |
| 2010-06-30 | 12.17% |
| 2010-03-31 | 12.91% |
| 2009-12-31 | 14.97% |
| 2009-09-30 | 17.54% |
| 2009-06-30 | 13.23% |
| 2009-03-31 | 14.21% |
| 2008-12-31 | 15.28% |
| 2008-09-30 | 15.76% |
| 2008-06-30 | 16.79% |
| 2008-03-31 | 25.49% |
| 2007-12-31 | 21.77% |
| 2007-09-30 | 27.76% |
| 2007-06-30 | 26.18% |
| 2007-03-31 | 17.16% |
| 2006-12-31 | 16.59% |
| 2006-09-30 | 12.38% |
| 2006-06-30 | 11.78% |
| 2006-03-31 | 10.91% |
| 2005-12-31 | 13.21% |
| 2005-09-30 | 12.00% |
| 2005-06-30 | 12.23% |
| 2005-03-31 | 13.09% |
| 2004-12-31 | 13.99% |
| 2004-09-30 | 16.54% |
| 2004-06-30 | 18.49% |
| 2004-03-31 | 19.58% |
| 2003-12-31 | 19.16% |
| 2003-09-30 | 20.30% |
| 2003-06-30 | 18.32% |